Bleeding and thrombosis in cancer patients

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    Cancer patients can suffer both bleeding and thrombotic complications which can have effects ranging from needing to have new or different therapies to being fatal. Bleeding complications can be due to therapy-related causes such as drug-induced thrombocytopenia or due to the cancer itself such as found in acute promyelocytic leukemia. The same dynamic holds true for thrombotic complications. This chapter will review both bleeding and thrombotic complications of cancer and its treatment focusing on pathogenesis, recognition, and treatment.

    Original languageEnglish (US)
    Title of host publicationOncologic Emergency Medicine: Principles and Practice
    PublisherSpringer International Publishing
    Pages235-242
    Number of pages8
    ISBN (Electronic)9783319263878
    ISBN (Print)9783319263854
    DOIs
    StatePublished - Jan 1 2016

    Fingerprint

    Thrombosis
    Hemorrhage
    Neoplasms
    Acute Promyelocytic Leukemia
    Therapeutics
    Thrombocytopenia
    Pharmaceutical Preparations

    Keywords

    • Acquired von Willebrand disease
    • Bleeding
    • Cancer
    • Thrombosis
    • Trousseau syndrome
    • VEGF inhibitors

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Deloughery, T. (2016). Bleeding and thrombosis in cancer patients. In Oncologic Emergency Medicine: Principles and Practice (pp. 235-242). Springer International Publishing. https://doi.org/10.1007/978-3-319-26387-8_20

    Bleeding and thrombosis in cancer patients. / Deloughery, Thomas.

    Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016. p. 235-242.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Deloughery, T 2016, Bleeding and thrombosis in cancer patients. in Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, pp. 235-242. https://doi.org/10.1007/978-3-319-26387-8_20
    Deloughery T. Bleeding and thrombosis in cancer patients. In Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing. 2016. p. 235-242 https://doi.org/10.1007/978-3-319-26387-8_20
    Deloughery, Thomas. / Bleeding and thrombosis in cancer patients. Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016. pp. 235-242
    @inbook{2ac0539e488f4857a3cd026b521346c6,
    title = "Bleeding and thrombosis in cancer patients",
    abstract = "Cancer patients can suffer both bleeding and thrombotic complications which can have effects ranging from needing to have new or different therapies to being fatal. Bleeding complications can be due to therapy-related causes such as drug-induced thrombocytopenia or due to the cancer itself such as found in acute promyelocytic leukemia. The same dynamic holds true for thrombotic complications. This chapter will review both bleeding and thrombotic complications of cancer and its treatment focusing on pathogenesis, recognition, and treatment.",
    keywords = "Acquired von Willebrand disease, Bleeding, Cancer, Thrombosis, Trousseau syndrome, VEGF inhibitors",
    author = "Thomas Deloughery",
    year = "2016",
    month = "1",
    day = "1",
    doi = "10.1007/978-3-319-26387-8_20",
    language = "English (US)",
    isbn = "9783319263854",
    pages = "235--242",
    booktitle = "Oncologic Emergency Medicine: Principles and Practice",
    publisher = "Springer International Publishing",

    }

    TY - CHAP

    T1 - Bleeding and thrombosis in cancer patients

    AU - Deloughery, Thomas

    PY - 2016/1/1

    Y1 - 2016/1/1

    N2 - Cancer patients can suffer both bleeding and thrombotic complications which can have effects ranging from needing to have new or different therapies to being fatal. Bleeding complications can be due to therapy-related causes such as drug-induced thrombocytopenia or due to the cancer itself such as found in acute promyelocytic leukemia. The same dynamic holds true for thrombotic complications. This chapter will review both bleeding and thrombotic complications of cancer and its treatment focusing on pathogenesis, recognition, and treatment.

    AB - Cancer patients can suffer both bleeding and thrombotic complications which can have effects ranging from needing to have new or different therapies to being fatal. Bleeding complications can be due to therapy-related causes such as drug-induced thrombocytopenia or due to the cancer itself such as found in acute promyelocytic leukemia. The same dynamic holds true for thrombotic complications. This chapter will review both bleeding and thrombotic complications of cancer and its treatment focusing on pathogenesis, recognition, and treatment.

    KW - Acquired von Willebrand disease

    KW - Bleeding

    KW - Cancer

    KW - Thrombosis

    KW - Trousseau syndrome

    KW - VEGF inhibitors

    UR - http://www.scopus.com/inward/record.url?scp=85013031891&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85013031891&partnerID=8YFLogxK

    U2 - 10.1007/978-3-319-26387-8_20

    DO - 10.1007/978-3-319-26387-8_20

    M3 - Chapter

    AN - SCOPUS:85013031891

    SN - 9783319263854

    SP - 235

    EP - 242

    BT - Oncologic Emergency Medicine: Principles and Practice

    PB - Springer International Publishing

    ER -